Journal
NATURE PROTOCOLS
Volume 5, Issue 6, Pages 1033-1041Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2010.73
Keywords
-
Categories
Funding
- ANRS
- Korea Science and Engineering Foundation
- Institut Pasteur Korea
Ask authors/readers for more resources
To advance T cell-based HIV vaccine development, it is necessary to evaluate the immune correlates of a protective CD8(+) T-cell response. We have developed an assay that assesses the capacity ex vivo of HIV-specific CD8(+) T cells to suppress HIV-1 infection of autologous CD4(+) T cells. this assay directly reflects the ultimate effector function of CD8(+) T cells, the elimination of infected cells, and accurately differentiates the effective CD8(+) T-cell response in spontaneous HIV controllers from ineffective responses in other patients. In this article, we describe all the steps from cell purification to assessment of viral replication by HIV-p24 ELISA and analysis, along with conditions for cell culturing, and how to choose the viral infectious dose that gives the most reliable results. We also depict the conditions of a rapid assay on the basis of flow cytometry analysis of intracellular HIV-Gag products. these procedures take 14-17 d when the p24 ELISA assay is used, or 6 d with the intracellular Gag assay.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available